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ABSTRACT
Parkinson’s disease is frequently associated with gastrointes-
tinal symptoms, mostly represented by constipation and
defecatory dysfunctions. This study examined the impact of
central dopaminergic denervation, induced by injection of
6-hydroxydopamine (6-OHDA) into the medial forebrain bundle,
on distal colonic excitatory cholinergic neuromotor activity in
rats. Animals were euthanized 4 and 8 weeks after 6-OHDA
injection. In vivo colonic transit was evaluated by radiologic
assay. Electrically induced and carbachol-induced cholinergic
contractions were recorded in vitro from longitudinal and circular
muscle colonic preparations, whereas acetylcholine levels were
assayed in the incubationmedia. Choline acetyltransferase (ChAT),
HuC/D (pan-neuronal marker), muscarinic M2 and M3 receptors
were assessed by immunohistochemistry or western blot assay. As
compared with control rats, at week 4, 6-OHDA–treated animals
displayed the following changes: decreased in vivo colonic transit
rate, impaired electrically evoked neurogenic cholinergic contrac-
tions, enhanced carbachol-induced contractions, decreased
basal and electrically stimulated acetylcholine release from co-
lonic tissues, decreased ChAT immunopositivity in the neuro-
muscular layer, unchanged density of HuC/D immunoreactive
myenteric neurons, and increased expression of colonic musca-
rinic M2 and M3 receptors. The majority of such alterations were
also detected at week 8 post 6-OHDA injection. These findings
indicate that central nigrostriatal dopaminergic denervation is
associated with an impaired excitatory neurotransmission char-
acterized by a loss of myenteric neuronal ChAT positivity and
decrease in acetylcholine release, resulting in a dysregulated
smooth muscle motor activity, which likely contributes to the
concomitant decrease in colonic transit rate.
Introduction
Parkinson’s disease (PD) is a common neurodegenerative
disorder, characterized by tremor, bradykinesia, and rigidity.
PD is also associated with gastrointestinal (GI) dysmotility,
including dysphagia, constipation, and defecatory disorder,
which contribute to PD morbidity (Braak et al., 2006; Cloud
and Greene, 2011; Pellegrini et al., 2015).
Eosinophilic cytoplasmic inclusions (Lewy bodies), contain-
ing aggregated a-synuclein, a hallmark of PD, have been
detected in the enteric nervous system (ENS) and dorsalmotor
nucleus of the vagus (DMV) in PD patients, suggesting that
the disease could spread from brain to gut (Wakabayashi and
Takahashi, 1997; Braak et al., 2006), or rather start from the
digestive system and move toward the brain (Hawkes et al.,
2007; Pan-Montojo et al., 2010). However, the mechanisms of
onset and progression linking PD to enteric dysmotility are
poorly understood.
Alterations associated with GI dysmotility have been in-
vestigated in PD patients and animal models of PD. In PD
models induced by systemic injection of 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine, rotenone, or salsolinol, GI motor
alterations were ascribed to direct effects of neurotoxins on
enteric neurons (Banach et al., 2005; Anderson et al., 2007;
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indole; ICSMC, isolated colonic smooth muscle cell; L-732,138, N-acetyl-L-tryptophan 3,5-bis(trifluoromethyl)benzylester; L-NAME, Nv-nitro-L-
arginine methylester; MFB, medial forebrain bundle; NK, neurokinin; 6-OHDA, 6-hydroxydopamine; SB218795, (R)-[(2-phenyl-4-quinolinyl)carbonyl)
amino]-methyl ester benzeneacetic acid; SNc, substantia nigra pars compacta; TBS, Tris-buffered saline; TH, tyrosine hydroxylase.
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Pan-Montojo et al., 2010). However, other authors observed
that, under denervation, elicited by 6-hydroxydopamine (6-
OHDA) injection into the medial forebrain bundle (MFB), GI
dysmotility appears to depend on nigrostriatal dopaminergic
degeneration (Blandini et al., 2009). In particular, neuro-
transmitter alterations (dopamine, nitric oxide, vasoactive
intestinal peptide), regulating intestinal motility, have been
documented in the 6-OHDA model (Colucci et al., 2012; Zhu
et al., 2012). PD-related GI abnormalities have also been
explored in transgenic models. Mice overexpressing human
wild-type or mutant A53T a-synuclein displayed moderate GI
dysfunctions, including reduced gastric emptying, increased
transit time, and reduced fecal output (Noorian et al., 2012).
Furthermore, changes in colonic myenteric ganglia and pro-
pulsive activity were observed in Thy1-aSyn mice, character-
ized by overexpression of human a-synuclein in colonic
myenteric ganglia (Wang et al., 2008, 2012). However, as no
consistent nigrostriatal degeneration is associated with syn-
uclein overexpression in these animals, at least at an early
age, such models might not be not suitable for studies
designed to pinpoint the impact of central dopaminergic
denervation on GI motility.
When considering possible alterations of enteric excitatory
pathways in PD, the available evidence is scarce and conflict-
ing. Some authors have observed that the choline acetyltrans-
ferase (ChAT) expression in the proximal colon of rats with
nigrostriatal denervation by 6-OHDA did not vary (Colucci
et al., 2012; Zhu et al., 2012), whereas in the same model, a
decreased acetylcholine content was found in the muscular
layer of rat stomach (Zheng et al., 2011). Recently, Sharrad
et al. (2013) reported that Lewy pathology targets both
intrinsic and parasympathetic cholinergic neurons in the
large bowel, suggesting the involvement of cholinergic path-
ways in bowel dysmotility associated with PD.
Despite several investigations supporting the view that GI
symptoms in PD are associated with alterations of enteric
nerve functions, the role played by cholinergic neurotrans-
mission in the onset and progression of bowel motor abnor-
malities remains unclear. Therefore, the present study
examined the impact of dopaminergic denervation by 6-OHDA
injection into the MFB on colonic excitatory cholinergic
neuromotility. In particular, functional studies were per-
formed to assess the in vivo colonic transit as well as in vitro
cholinergic contractile activity and acetylcholine release,
whereas the evaluation of cholinergic neuron density and
muscarinic receptor expression in the colonic neuromuscular
layer was carried out by means of molecular approaches.
Materials and Methods
Animals. Male Sprague-Dawley rats (bodyweight 200–250 g)were
used throughout the study. The animals were fed standard laboratory
chow and tap water ad libitum and were not used for at least 1 week
after their delivery to the laboratory. They were housed, three in a
cage, in temperature-controlled rooms on a 12-hour light cycle at
22–24°C and 50–60% humidity. Their care and handling were in
accordance with the provisions of the European Community Council
Directive 86-609, recognized and adopted by the Italian government.
Induction of Nigrostriatal Denervation. Animals were anes-
thetized with 50 mg/kg sodium thiopental (i.p.) and placed into a
stereotaxic frame (Stoelting, Wood Dale, IL). Rats received 6-OHDA
(dissolved in saline solution containing 0.02% of ascorbic acid) or
saline unilaterally into two sites of the right MFB, at the following
coordinates (in millimeters) relative to the bregma and dural surface:
1) antero-posterior524.0, medium-lateral 520.8, dorso-ventral (DV)5
28.0 tooth bar at 13.4 (9 mg /3 ml); and 2) antero-posterior 5 24.4,
medium-lateral 5 21.2, DV 5 27.8 tooth bar at 22.4 (7.5 mg /3 ml)
(Paxinos and Watson, 1998). The injection rate was 1 ml/min using a
Hamilton 10-ml syringe mounting a 26-gauge needle. After injection, the
needle was left in place for 5 minutes to avoid leaks. At the end of the
process, wounds were clipped, and the animal was allowed to wake up
and recover. Animals were euthanized 4 and 8 weeks following 6-OHDA
injection. Brains were immediately removed, frozen on dry ice, and stored
at 280°C, whereas colonic specimens were dissected and processed for
functional experiments and other assays as described later.
Immunohistochemistry of Tyrosine Hydroxylase in Brain
Sections. Serial coronal sections (40mm), including the striatum and
substantia nigra pars compacta SNc) from both sham-operated and
6-OHDA animals, were cut on a cryostat and mounted on polylysine-
coated slides. Immunohistochemical staining for tyrosine hydroxylase
(TH)was carried out to evaluate dopaminergic terminal damage in the
striatum and loss of cell bodies in the SNc, as previously described
(Blandini et al., 2004). In brief, sections containing the striatum and
SNc were postfixed in cold, 4% neutral buffered formaldehyde (Carlo
Erba, Milan, Italy); rinsed in Tris-buffered saline (TBS); treated with
3% H2O2; and incubated in TBS containing 10% normal goat serum
together with 0.6% Triton X-100 for 30 minutes at room temperature.
Sections were incubated overnight at 4°C with a mouse anti-TH
antibody (1:2000; Chemicon International, Temecula, CA), then
rinsed in TBS and incubated for 60 minutes at room temperature
with a goat biotinylated anti-mouse IgG antibody (1:1000; Vector
Laboratories, Burlingame, CA). Finally, sections were processed with
the avidin-biotin technique using a commercial kit (Vectastain ABC
Elite kit; Vector Laboratories), and reaction products were developed
using nickel-intensified 3,39-diaminobenzidine tetrahydrochloride
(DABSubstrateKit for Peroxidase; Vector Laboratories). After rinsing
with TBS, sections were dehydrated in ascending alcohol concentra-
tions, cleared in xylene (Carlo Erba), and coverslipped.
Evaluation of Nigrostriatal Degeneration. The striatal dopa-
minergic terminal damage resulting from 6-OHDA infusion into the
MFB was detected by the absence of TH staining within the striatum
and expressed as the percentage of striatal volume deprived of TH
immunoreactivity, as compared with the overall striatal volume. The
striatal expression of TH was also evaluated in the brains of sham-
operated animals.
The total number of dopaminergic cells in the SNc of both
hemispheres was counted using stereological analysis. Unbiased
stereological estimation was performed using the optical fractionator
method (West et al., 1991) by the Stereo Investigator software on a
Neurolucida computer-controlled microscopy system (Microbright-
field Inc., Williston, VT). The boundaries of SNc at all levels in the
rostrocaudal axis were defined with reference to a coronal atlas of the
rat brain (Paxinos and Watson, 1998). TH-positive cells in the SNc
were counted in every fourth section, on comparable sections for all
experimental groups throughout the whole nucleus. Counting frames
(75  75 mm) were placed at the intersections of a grid (frame size
208,65  161,6 mm) that had been randomly placed over the section.
Cells were labelled if they were TH-positive and were in focus within
the counting area. Results represent the percentage of the number of
TH-positive neurons in the injected SNc with respect to the intact side
(neuron survival). We set 98% at the cut-off level for the striatal lesion
and 95% for the lesion in the SNc.
Radiologic Assessment of Colonic Transit. The radiologic
assessment of overall in vivo colonic transit was performed as
previously described (Vegezzi et al., 2014). In brief, 4 and 8 weeks
after 6-OHDA or saline nigrostriatal injection, overnight fasted rats
received a suspension of BaSO4 (2.5 ml, 1.5 g/ml; Prontobario H.D.,
Bracco Imaging Italia, Milan, Italy) intragastrically, and radiographic
exposures were taken 10 and 12 hours later. This time frame was
previously shown to allow the detection of contrast medium in
radiographs of the cecal and colorectal regions. Focus-film distance
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was manually fixed at 100 cm, and exposure values were 65 kVp to
4.5 mA (exposure time: 0.01 second). Total body DV radiographic
projections were considered. The analysis of radiographic images
was carried out according to the scoring proposed by Cabezos et al.
(2008) by 6 different observers blinded to the treatment. In detail, the
proportion of labeled cecum and colorectum, the intensity of labeling,
the organ profile, and the homogeneity of labeling within the organ
were all evaluated by each blinded observer and scored for each
animal to obtain an overall value ranging from 0 to 12. The score for
each rat was themean of six readings. Final data were themeans from
eight rats per group.
Recording of Colonic Contractile Activity In Vitro. Contrac-
tile activity of colonic longitudinal and circular smooth muscle was
recorded as previously described (Antonioli et al., 2014). After eutha-
nization, the colon was removed and placed in cold Krebs’ solution.
Longitudinal and circular muscle strips from the distal colon, approx-
imately 3 mm wide and 20 mm long, were set up in organ baths
containing Krebs’ solution at 37°C, bubbled with 95% O2 1 5% CO2.
The strips were connected to isometric force transducers (2Biological
Instruments, Besozzo, VA, Italy). A tension of 0.5 g for circular muscles
and 1.0 g for longitudinal muscles was slowly applied to the prepara-
tions. Mechanical activity was recorded by BIOPAC MP150 (2Biological
Instruments). Krebs’ solution had the following composition (in mM):
NaCl 113, KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25,
and glucose 11.5 (pH 7.460.1). Each preparation was allowed to
equilibrate for at least 30 minutes, with intervening washings at
10-minute intervals. A pair of coaxial platinum electrodes were
positioned at a distance of 10 mm from the longitudinal axis of
each preparation to deliver transmural electrical stimulation by a
BM-ST6 stimulator (Biomedica Mangoni, Pisa, Italy). Electrical
stimuli (ES) were applied as follows: 10-second single trains consisting
of square wave pulses (0.5 ms, 30 mA). At the end of the equilibration
period, each preparation was repeatedly challenged with electrical
stimuli (10 Hz), and experiments were started when reproducible
responses were obtained (usually after two or three stimulations).
Frequency-response curves (from 1 to 20 Hz) were constructed under
the different in vitro experimental conditions reported later. The tension
developed by each preparation was normalized by the wet tissue weight
and expressed as grams per gram of wet tissue (g/g tissue).
In the first set of experiments, electrically evoked motor responses
were recorded from colonic preparations maintained in standard
Krebs’ solution.
In the second series of experiments, contractions were assessed in
colonic preparations maintained in Krebs’ solution containing Nv-nitro-
L-arginine methylester (L-NAME; 100 mM), guanethidine (10 mM),
N-acetyl-L-tryptophan 3,5-bis(trifluoromethyl)benzylester (L-732,138,
neurokinin NK1 receptor antagonist; 10 mM), 5-fluoro-3-[2-[4-
methoxy-4-[[(R)-phenylsulphinyl]methyl]-1-piperidinyl]ethyl]-1H-indole
(GR159897, NK2 receptor antagonist; 1 mM), and (R)-[[(2-phenyl-4-
quinolinyl)carbonyl]amino]-methyl ester benzeneacetic acid (SB218795,
NK3 receptor antagonist; 1 mM) to examine the patterns of colonic
contractions driven by excitatory nerve cholinergic pathways.
In the third series, colonic cholinergic contractions where evoked by
direct pharmacological activation of muscarinic receptors located on
smooth muscle cells. For this purpose, colonic preparations were
maintained in Krebs’ solution containing tetrodotoxin (1 mM) and
stimulated with carbachol (0.01–100 mM).
Measurement of Acetylcholine Release from Colonic Lon-
gitudinal Muscle Preparations. Longitudinal muscle strips of
colon, containing the myenteric plexus, were prepared and incubated
in Krebs’ solution containing L-NAME, guanethidine, L-732,138,
GR159897, and SB218795 as reported earlier. After equilibration,
aliquots of Krebs’ solution (200 ml) were collected at 2300, 2180,
260, 160, 1180, and 1300 seconds with respect to the onset of ES
(0.5 ms, 30 mA, 10 Hz). At the end of the 10-second period of ES
application, one additional aliquot was collected to evaluate the amount
of electrically induced acetylcholine release, as previously described by
Yajima et al. (2011). To better appreciate the alterations of electrically
Fig. 1. Representative images of dopaminergic (TH+) striatal terminals
and SNc cell bodies of both sham-operated and 6-OHDA–lesioned animals.
Scale bar: 500 mm.
Fig. 2. Radiographic contrast study of large bowel motor function in
control rats and animals 4 and 8 weeks after nigrostriatal denervation
with 6-OHDA. Total score was assessed 10 and 12 hours after barium
sulfate gavage in the cecum (A) and colorectum (B). Each column
represents the mean 6 S.E.M. score obtained from eight animals.
Statistics: Kruskal-Wallis test followed by Dunn’s post-test. *P , 0.05,
significant difference versus control.
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evoked acetylcholine release, the variations of acetylcholine con-
centrations in the bathing fluid upon application of electrical stim-
ulation were calculated for each group as a percentage of the values
at the end of the 10-second stimulation period over the baseline values
assessed at 260 seconds. Aliquots were stored at 280°C to determine
acetylcholine content (Choline/AcetylcholineAssayKit;Abcam,Cambridge,
UK). Acetylcholine release was expressed as choline concentration
normalized to the weight of the colonic preparation.
Immunohistochemistry of HuC/D and ChAT. Sections (8 mm)
from formalin-fixed full-thickness distal colonic samples were pro-
cessed for immunostaining, as described by Ippolito et al. (2015). In
brief, sections were incubated overnight at 4°C with primary anti-
bodies against the pan-neuronal HuC/D (A-21271; Molecular Probes,
Eugene, OR) and ChAT (Mab AP144P; Chemicon, Temecula, CA), and
then exposed to biotinylated immunoglobulins, peroxidase-labeled
streptavidin complex, and 3.39-diaminobenzidine tetrahydrochloride
(DakoCytomation, Glostrup, Denmark). Five sections for each colonic
sample (n 5 6 animals per group) were examined by a Leica DMRB
light microscope, and representative photomicrographs were taken by
a DFC480 digital camera (Leica Microsystems, Cambridge, UK) for
quantitative evaluation. Neuronal density was estimated as the
number of HuC/D-immunostained cells within the ganglionic area.
To measure the myenteric ganglionic area, a morphometric analysis
was carried out on 10microscopic fields per section, randomly selected
along the myenteric ridge and captured with a 40 objective using the
Image Analysis System L.A.S. software version 4.5 (Leica Micro-
systems); the ganglia were then highlighted and their area was
expressed in mm2. ChAT expression was evaluated as positive pixels
on the total ganglionic tissue area examined and expressed as a
percentage of positive pixels. Quantitative variations were expressed
as fold changes, which were calculated as the ratio of the final value
over the initial value.
Isolated Colonic Smooth Muscle Cells. Rat colonic smooth
muscle cells were explanted from tunica muscularis, as described by
Ippolito et al. (2015). In brief, colonic specimens from controls and
6-OHDA rats at week 4 were washed repeatedly with cold, sterile
phosphate-buffered saline, and the muscular layers were separated
from the mucosa and submucosa. The specimens of colonic muscular
tissue were then minced and incubated in complete Dulbecco’s
modified Eagle’s medium (Gibco, Life Technology Italia, Monza, Italy)
under 5%CO2 at 37°C. Upon confluence, the explants were dissociated
by trypsin. Isolated colonic smooth muscle cells (ICSMCs) were then
maintained in Dulbecco’s modified Eagle’s medium added with 10%
fetal bovine serum and used until the fifth passage. Care was taken to
verify that ICSMCs displayed and maintained a smooth muscle cell
phenotype by immunostaining for standardmarkers (Nair et al., 2011)
(data not shown).
Western Blot Analysis of Muscarinic M2 and M3 Receptors
in Colonic Tissues and ICSMCs. Colonic specimens were dis-
sected to separate the mucosal/submucosal layer from underlying
neuromuscular tissues. Samples of colonicmuscular tissue or ICSMCs
were homogenized in radioimmunoprecipitation assay lysis buffer
(Cole Parmer homogenizer, Milan, Italy). Homogenates were spun by
centrifugation at 20,000 rpm for 15 minutes at 4°C. Supernatants
were then separated from pellets and stored at 280°C. Protein con-
centration was determined by the Bradford method (Protein Assay
Kit; Bio-Rad, Hercules, CA). Equivalent amounts of protein lysates
(50mg for both tissues and ICSMCs) were separated by 8%SDS-PAGE
for immunoblotting. After transfer onto a polyvinylidene fluoride mem-
brane, the blots were blocked and incubated overnight with a rabbit anti-
M2 antibody (MR002; Alomone Laboratories, Jerusalem, Israel) or a
rabbit anti-M3 antibody (87199; Abcam). After repeated washings with
Tris-Buffered saline and Tween 20 buffer, appropriate secondary
peroxidase-conjugated antibodies (Santa Cruz Biotechnology, Santa Cruz,
CA) were added for 1 hour at room temperature. Immunoreactive bands
were then visualized by incubation with chemiluminescent reagents
(Immobilon reagent; Millipore, Billerica, MA) and examined by Kodak
Image Station 440 (Celbio, Milan, Italy) for signal detection. To ensure
equal sample loading, blots were stripped and reprobed for determination
of b-actin by a specific antibody (P5747; Sigma-Aldrich, Milan, Italy).
Drugs and Solutions. Atropine sulfate, guanethidine monosul-
fate, carbachol chloride, Nv-nitro-L-arginine methylester, 6-hydroxy
dopamine, and ascorbic acid were purchased from Sigma Chemicals
Co. (St. Louis, MO). Tetrodotoxin, L-732,138, GR159897, and
SB218795 were purchased from Tocris (Bristol, UK). Mouse anti-TH
antibody was purchased from Chemicon International. Biotinylated
anti-mouse IgG antibody and nickel-intensified 3,39-diaminobenzidine
tetra-hydrochloride (DABSubstrateKit for Peroxidase) were purchased
A B
Fig. 3. Effects of ES (1–20 Hz) on the mechanical activity of colonic longitudinal (A) and circular (B) smooth muscle preparations isolated from control
animals or rats 4 and 8 weeks after nigrostriatal denervation with 6-OHDA. Colonic preparations were maintained in standard Krebs’ solution. Tracings
in the inset on the top of each panel display contractile responses to ES recorded at a frequency of 10 Hz. Each column represents the mean 6 S.E.M.
obtained from eight animals. Statistics: one-way analysis of variance followed by post-hoc analysis with Student-Newman-Keuls test. *P , 0.05,
significant difference versus control.
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from Vector Laboratories (Burlingame, CA). Xylene was purchased
from Carlo Erba.
Statistical Analysis. The results are presented as the mean6 S.
E.M. unless otherwise stated. The significance of differences was
evaluated by Student’s t test for paired or unpaired data or one-way
analysis of variance followed by post-hoc analysis with Student-
Newman-Keuls or Bonferroni tests. Data regarding colonic transit
time were analyzed by Kruskal-Wallis test followed by Dunn’s post-
test. P values ,0.05 were considered significantly different. All
statistical procedures were performed by commercial software
(GraphPad Prism, version 3.0; GraphPad Software Inc., San
Diego, CA).
Results
Immunohistochemical Analysis of TH in Brain. The
unilateral injection of 6-OHDA into the MFB caused a
virtually complete loss of dopaminergic striatal terminals
(98%) and dopaminergic nigral neurons (95%) of the right
(injected) hemisphere, both at week 4 and at week 8. Animals
bearing lesions of less than 98% in the striatum and 95% in
the SNc were excluded from the study. Sham-operated rats
did not display differences in TH immunoreactivity between
hemispheres both at week 4 and at week 8 (Fig. 1).
In Vivo Colonic Transit. Radiologic findings in the
cecum and colorectum of control and 6-OHDA rats were
compared and scored at weeks 4 and 8 from the induction of
nigrostriatal denervation (n 5 8 animals for each treatment
group). Both 10 and 12 hours after gavage with BaSO4, the
scores of control and 6-OHDA rats, calculated for cecum
radiographs, were higher than colorectal values, indicating
that, at those times, the medium had reached both the more
proximal portion of the large bowel (cecum radiographs) and
the more distal region of the large intestine (colorectal
radiographs) (Fig. 2).
In both cecal and colorectal areas, total scores estimated for
6-OHDA animals were lower than those estimated for con-
trols. In particular, after 8 weeks from 6-OHDA injection, a
significant reduction of total scores was obtained in both the
cecum and colorectum (Fig. 2).
In Vitro Colonic Contractile Activity. In colonic longi-
tudinal muscle preparations (from 6-OHDA rats) maintained
in standard Krebs’ solution, electrically evoked motor
TABLE 1
Effects of atropine (1 mM) on electrically and carbachol-evoked cholinergic mechanical responses in isolated colonic tissues
ES-evoked cholinergic responses were recorded in tissues maintained in Krebs’ solution containing L-NAME (100 mM), guanethidine (10 mM), L-732,138 (10 mM), GR159897 (1
mM), and SB218795 (1 mM). Carbachol-induced motor responses were recorded in tissues maintained in Krebs’ solution containing tetrodotoxin (1 mM). The effects of atropine
were expressed as percentage of reductions versus contractions recorded in the absence of atropine. Each number represents the mean6 S.E.M. value obtained from five to six
animals (statistics: one-way analysis of variance followed by post-hoc analysis with Student-Newman-Keuls test).
Colonic Layer
Percentage of Reduction of Contractile Response to ES at 10 Hz Percentage of Reduction of Contractile Response to 1 mM Carbachol
Control 6-OHDA, 4 Weeks 6-OHDA, 8 Weeks Control 6-OHDA, 4 Weeks 6-OHDA, 8 Weeks
Longitudinal 93.4 6 4.1 96.2 6 5.6 98.7 6 6.9 96.5 6 8.1 89.9 6 6.4 98.8 6 4.9
Circular 97.0 6 3.8 91.1 6 5.5 99.2 6 5.8 91.9 6 6.0 99.7 6 5.5 95.9 6 7.1
A B
Fig. 4. Effects of ES (1–20 Hz) on the mechanical activity of colonic longitudinal (A) and circular (B) smooth muscle preparations isolated from control
animals or rats 4 and 8 weeks after nigrostriatal denervation with 6-OHDA. Colonic preparations were maintained in Krebs’ solution containing
L-NAME (100 mM), guanethidine (10 mM), L-732,138 (10 mM), GR159897 (1 mM), and SB218795 (1 mM) to record cholinergic contractions. Tracings in
the inset on the top of each panel display contractile responses to ES recorded at a frequency of 10 Hz. Each column represents the mean 6 S.E.M.
obtained from eight animals. Statistics: one-way analysis of variance followed by post-hoc analysis with Student-Newman-Keuls test. *P , 0.05,
significant difference versus control.
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responses were decreased both at week 4 (significant differ-
ence at 20 Hz) and at week 8 (significant difference at all
tested frequencies) after 6-OHDA injection, as compared with
contractions recorded from control preparations (n 5 8
animals for each treatment group) (Fig. 3A). Likewise, in
colonic circular muscle preparations from 6-OHDA rats after 4
or 8 weeks (n 5 8 animals for each treatment group), the
electrically evoked contractile activity was significantly re-
duced at all tested frequencies (Fig. 3B).
In colonic longitudinal and circular muscle preparations
maintained in Krebs’ solution containing L-NAME, guaneth-
idine, and NK receptor antagonists, the application of elec-
trical stimulation elicited contractile responses, which were
abolished by atropine (Table 1) or tetrodotoxin, while being
slightly affected by hexamethonium, indicating the recruit-
ment of postganglionic cholinergic motor neurons (not shown).
Under these conditions, electrically evoked cholinergic con-
tractions were decreased at both weeks 4 and 8 in comparison
with controls (n5 8 animals for each treatment group) (Fig. 4,
A and B).
The exposure of colonic longitudinal and circular muscle
preparations to carbachol (0.001–100 mM), in the presence of
tretrodotoxin (1 mM), elicited concentration-dependent con-
tractions (Table 1), which were abolished by atropine and
were significantly enhanced in preparations from rats at
both 4 and 8 weeks after 6-OHDA injection, as compared
with control (n 5 8 animals for each treatment group) (Fig. 5,
A and B).
Acetylcholine Release. Acetylcholine concentrations in
aliquots of Krebs’ solution collected upon ES were almost
suppressed by incubationwith tetrodotoxin (1mM). In aliquots
of medium collected under resting conditions, acetylcholine
concentrations, assessed for colonic longitudinal muscle prep-
arations from 6-OHDA rats, were lower at both week 4 and
week 8, as compared with controls (Fig. 6A). Upon exposure of
control colonic strips to ES, acetylcholine release into Krebs’
solution increased by 150% versus the baseline value assessed
at 260 seconds, whereas in preparations from 6-OHDA animals,
the percentage of evoked acetylcholine release was lower as
compared with controls (130% versus baseline at week 4 and
128% versus baseline at week 8, respectively; n 5 8 animals
for each treatment group) (Fig. 6B).
Immunohistochemical Analysis of HuC/D and ChAT.
Preliminarily to neuronal counting, the area of myenteric
ganglia was quantitatively estimated, and no significant
changes were found among the experimental groups, as shown
by the following mean values: controls, 2.82 6 0.38  1023
mm2; 6-OHDA rats at week 4, 2.75 6 0.29  1023 mm2;
6-OHDA rats at week 8, 2.446 0.25 1023 mm2. With regard
to neurons, strong cytoplasmic and/or nuclear HuC/D immu-
nostaining was detected in myenteric neurons of distal colons
from controls and rats with 6-OHDA–induced nigrostriatal
denervation. The total number of HuC/D immunoreactive
myenteric neurons did not change in 6-OHDA rats at both
week 4 and week 8, as compared with controls. By contrast, a
significant decrease in ChAT immunopositivity was detected
in themyenteric ganglia of 6-OHDA rats at both weeks 4 and 8
(261.0 and 236.1% versus controls, respectively; n 5 6
animals for each group of treatment) (Fig. 7).
Western Blot Analysis of Muscarinic M2 and M3
Receptor Expression. Western blot analysis revealed the
constitutive expression of both muscarinic M2 and M3 recep-
tors in colonic neuromuscular tissues from control rats (Fig.
8A). In colonic tissues obtained from rats at weeks 4 and 8
after treatment with 6-OHDA, a significant increase in the
expression of both receptor subtypes was detected (n 5 5–6
animals for each treatment group) (Fig. 8A). In ICSMCs from
control rats, western blot analysis confirmed the basal
expression of both muscarinic M2 and M3 receptors. At week
4 after nigrostriatal denervation by 6-OHDA, the expression of
both receptor subtypes in ICSMCs significantly increased (n5
5–6 animals for each treatment group) (Fig. 8B).
Discussion
PD is associated with alterations of gut motor functions
(Cloud and Greene, 2011; Pfeiffer, 2011; Pellegrini et al.,
2015), which have been proposed to result both from an early
Fig. 5. Effects of increasing concentrations of carbachol (Cch; 0.01–100
mM) on the contractile activity of colonic longitudinal (A) and circular (B)
smooth muscle preparations isolated from control animals or rats 4 and
8 weeks after nigrostriatal denervation with 6-OHDA. Colonic prepara-
tions were maintained in Krebs’ solution containing tetrodotoxin (1 mM).
Tracings in the inset on the top of each panel display contractile responses
to carbachol at a concentration of 10 mM. Each point represents the mean
6 S.E.M. value obtained from eight animals. Statistics: one-way analysis
of variance followed by post-hoc analysis with Student-Newman-Keuls
test. *P , 0.05, significant difference versus control.
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impairment of the ENS and as a consequence of central
nigrostriatal degeneration associated with dopaminergic de-
nervation. In this context, our purpose was to evaluate the
impact of nigrostriatal dopaminergic denervation on the
patterns of colonic motility and related cholinergic control.
Indeed, current data on the abnormalities of colonic choliner-
gic neuromotor control in PD are scarce and inconsistent.
Thus, we aimed at characterizing the alterations occurring in
the 6-OHDA model by a multidisciplinary functional, molec-
ular, and morphologic approach. Overall, our results provide
convincing evidence that the induction of nigrostriatal de-
nervation, which reflects one of themain pathologic hallmarks
of PD, is associated with significant alterations of colonic
excitatory cholinergic neurotransmission, resulting in abnor-
mal patterns of in vivo transit and in vitro contractility.
The radiologic analysis documented that 4 weeks after
neurotoxin injection, the rats displayed a cecum total score
comparable to control animals, whereas colorectum score
values were lower than those of controls, suggesting a delay
in the transit of contrast medium within the large bowel.
A further delay was observed in rats 8 weeks after 6-OHDA
injection. In this case, the cecum total score was significantly
lower than in control animals, indicating a slow transit along
the small intestine. However, in these animals, the colorectum
score calculated 12 hours after bariumgavagewas higher than
after 10 hours, indicating a delay in colorectum filling. These
Fig. 6. (A) Acetylcholine content in aliquots of Krebs’ solution incubating colonic longitudinal muscle preparations from control animals or rats after 4
and 8 weeks from nigrostriatal denervation with 6-OHDA. Aliquots were collected at2300,2180,260, +60, +180, and +300 seconds with respect to the
onset of ES (10 Hz). One additional aliquot was collected at the end of the 10-second period of ES application to evaluate the electrically induced
acetylcholine release. Statistics: one-way analysis of variance followed by post-hoc analysis with Student-Newman-Keuls test. *P , 0.05, significant
difference versus control values. (B) Percent increments of acetylcholine levels in response to ES, calculated over the respective values assessed at 260
seconds, in Krebs’ solution incubating longitudinal muscle preparations from control animals or rats 4 and 8 weeks after nigrostriatal denervation with
6-OHDA. Each column represents the mean 6 S.E.M. obtained from eight animals. Statistics: Student’s t test for paired data or one-way analysis of
variance followed by Bonferroni’s post-test. aP , 0.05 versus the respective value at 260 seconds. Ach, acetylcholine.
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findings suggest that the model of 6-OHDA–induced nigro-
striatal degeneration is suitable for the assessment of bowel
dysmotility associated with PD. Consistently, evidence indicates
that a decreased rate of bowel movements and severe con-
stipation represent the most widely recognized clinical signs
of enteric dysfunction in PD patients (Pfeiffer, 2011). In
Fig. 7. Representative pictures of HuC/D andChAT immunostaining of rat colonic specimens. Myenteric ganglia from control and 6-OHDA rats showHuC/D
immunoreactive neurons (A, C, and E) without changes in neuron density (G). Myenteric neurons of control colons contain abundant amounts of ChAT
staining, which is significantly decreased in 6-OHDA rats (B, D, F, and H). ChAT immunostaining was validated in the rat central nervous system, which is
regarded as a positive control tissue (b). Scale bar = 100 mm. (G andH) The column graphs display themean values of neuron density (neurons/mm2)6S.E.M.
obtained from six animals. Statistics: one-way analysis of variance followed by post-hoc analysis with Student-Newman-Keuls test. *P, 0.05 versus controls.
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addition, our in vivo results are in keeping with previous data,
showing a reduced efficiency of in vitro peristalsis in colonic
preparations from rats with 6-OHDA–induced nigrostriatal
denervation (Colucci et al., 2012).
To verify whether the changes of in vivo propulsive colonic
motility might depend on underlying alterations of enteric
neurotransmission, we focused on the patterns of in vitro
excitatory cholinergic motor activity. Our results showed that
electrically evoked cholinergic contractions of colonic muscle
from 6-OHDA rats were decreased, indicating an altered
excitatory control of colonic motility. These findings provide
the first demonstration that central nigrostriatal denervation
is associated with a significant impairment of excitatory
cholinergic motility in the large bowel, and they add new
knowledge to the pathophysiological mechanisms underlying
the occurrence of intestinal alterations in PD (Zhu et al.,
2012). We then went on to assess whether these motor
abnormalities could depend on changes in the density of
myenteric nerves. To pursue this aim, we carried out immu-
nohistochemical assays in which myenteric ganglia were
labeled with the neuronal marker HuC/D and ChAT, a specific
marker of cholinergic neurons. In these experiments, colonic
tissues from 6-OHDA rats displayed a significant decrease in
immunopositivity for ChAT, whereas the overall density of
HuC/D1 myenteric neurons did not vary, suggesting that
nigrostriatal denervation leads to a reduced expression of
ChAT in myenteric cholinergic neurons, likely resulting in an
impairment of colonic cholinergic neurotransmission. Of note,
Toti and Travagli (2014) recently described a reduced density
of ChAT1 myenteric neurons in the upper GI tract, without
a concomitant variation of total neuronal density in 6-OHDA
rats. In line with this picture, evidence of unchanged overall
density of myenteric neurons was previously obtained in
patients with PD, suggesting that PD-related GI dysmotility
is not associated with a loss of neurons in the myenteric
plexus but rather with alterations in the chemical coding of
specific enteric neurons (Annerino et al., 2012).
To test the hypothesis that the decrease in colonic ChAT
would translate into a hampered enteric cholinergic neuro-
transmission, we assessed the levels of acetylcholine released
from in vitro colonic preparations into incubation medium.
Our results showed that, in 6-OHDA rats, the acetylcholine
output from colonic neuromuscular strips was significantly
decreased (both under basal conditions and in response to
electrical stimulation), as compared with controls. Therefore,
it appears that the decrease in myenteric ChAT expression,
which follows central nigrostriatal denervation, results in an
impairment of acetylcholine release from colonic myenteric
neurons. In line with this view, evidence of altered cholinergic
neurotransmission has been previously observed in the stom-
ach of 6-OHDA rats where nigrostriatal denervation led to a
reduced acetylcholine content in the muscularis externa and a
significant delay in gastric emptying (Zheng et al., 2011). In
addition, a correlation between the amount of acetylcholine
released from myenteric neurons and the magnitude of
electrically evoked contractions has been previously demon-
strated in isolated distal colonic preparations from rats with
experimental colitis (Poli et al., 2001). Therefore, taken
together with a reduced ChAT localization in myenteric
ganglionic neurons (as observed in our experiments), all of
these findings suggest that the impairment of colonic cholin-
ergic motility, following central 6-OHDA–induced denerva-
tion, depends on an impairment of acetylcholine release from
postjunctional myenteric motor neurons. However, the possi-
bility that the central dopaminergic neurodegeneration could
also affect other classes of myenteric cholinergic neurons
(i.e., intrinsic primary afferent neurons and/or interneurons)
cannot be ruled out.
In addition to an impaired neurogenic cholinergic motor
activity in the colon of 6-OHDA rats, we also observed an
enhancement of colonic myogenic responses elicited by direct
activation of muscarinic receptors with carbachol. Based on
our results, supporting a decrease in the release of acetylcho-
line from myenteric cholinergic neurons of 6-OHDA animals,
we hypothesized that this finding resulted from an upregu-
lation of muscular muscarinic receptors occurring as a
compensatory response to the impairment of cholinergic
neurotransmission. To address this issue, we examined the
expression of muscarinic M2 and M3 receptors in specimens
of the colonic neuromuscular layer as well as in ICSMCs by
western blot assays, and found that both receptor subtypes
were indeed upregulated in the colon of 6-OHDA rats. Of
Fig. 8. Western blot analysis of muscarinic
M2 and M3 receptors in the colonic neuromus-
cular layer (A) and ICSMCs (B) from control
rats and animals 4 and 8 weeks after nigro-
striatal denervation with 6-OHDA. Each col-
umn represents the mean 6 S.E.M. value
obtained from five to six animals. Statistics:
Student’s t test for unpaired data or one-way
analysis of variance followed by post-hoc anal-
ysis with Student-Newman-Keuls test. *P ,
0.05, significant difference versus control.
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note, compensatory increments of muscarinic receptor den-
sity, as a consequence of cholinergic denervation, have been
previously described in the colons of patients with divertic-
ular disease, where cholinergic denervation and related
motor abnormalities of isolated colonic muscle were associ-
ated with an upregulation of muscular muscarinic M3
receptors (Golder et al., 2003). Overall, it is conceivable that
the lowering of colonic transit in 6-OHDA rats depends, at
least in part, on the impairment of cholinergic enteric
neurotransmission.
In addition to the alterations of the cholinergic pathway
observed in the present study, it has been previously appre-
ciated that central dopaminergic neurodegeneration could
affect different neuromotor systems. For instance, Colucci
et al. (2012) observed a significant increase in vasoactive
intestinal polypeptide levels and a concomitant decrease in
neuronal nitric oxide synthase expression in the myenteric
plexus of the distal ileum and proximal colon of 6-OHDA rats.
In addition, Levandis et al. (2015) recently found that rats
with central denervation induced by 6-OHDA displayed an
altered colonic dopaminergic motor control, characterized by a
loss of inhibitory effects mediated by dopamine D2 receptors
on peristalsis, along with a reduced receptor expression and
increased dopamine levels. Therefore, the overall current
knowledge supports the notion that colonic dysmotility asso-
ciated with central dopaminergic denervation results from
alterations occurring at the level of different neuromotor
pathways.
The changes in colonic cholinergic neurotransmission, as
highlighted by the present investigations, lend further sup-
port to the available knowledge about the existence of a close
link between brain and gut. In this regard, increasing
evidence suggests that the DMV, which is known to provide
most of the parasympathetic innervation to the GI tract
(Jellinger, 1987), is one of the central nervous system sites
affected by PD pathology at its early stage (Del Tredici et al.,
2002). Indeed, neurochemical changes affecting the ENS, after
central dopaminergic denervation, have been shown to depend
on alterations of the DMV, which is regulated by brainstem
dopaminergic circuitries and represents a prominent target of
PD-related neurodegenerative processes (Braak et al., 2003,
2004; Zheng and Travagli, 2007; Zheng et al., 2011). In this
regard, the vagus nerve has been proposed to play a crucial
role in the regulation of inflammatory responses, a function
also referred to as the “cholinergic anti-inflammatory path-
way” (Matteoli andBoeckxstaens, 2013). In particular, there is
evidence that the vagus nerve exerts tonic anti-inflammatory
actions and contributes to the maintenance of intestinal
homeostasis (Matteoli and Boeckxstaens, 2013), whereas
vagotomy confers an increased susceptibility to the develop-
ment of inflammatory bowel diseases (Ghia et al., 2006). In
addition, Toti and Travagli (2014) recently found a reduced
expression of ChAT in the DMV of rats with 6-OHDA–induced
nigrostriatal denervation. Based on this knowledge, it is
conceivable that 6-OHDA–induced nigrostriatal denervation
might impair the DMV–vagus nerve anti-inflammatory path-
way, and that this alteration might result in a condition of
mild chronic bowel inflammation, leading to persistent dys-
functions in the enteric neuromuscular compartment. In
keeping with this hypothesis, in preliminary experiments,
we found that the levels of two inflammatory parameters
(tumor necrosis factor and malondialdehyde), were increased
in colonic tissues from 6-OHDA rats, thus suggesting that
experimental nigrostriatal denervation is associated with
inflammatory activity and related oxidative stress in the
colonic wall (M. Fornai, unpublished data). Of interest, our
preliminary observations are consistent with the findings of a
previous study, which showed an increase in proinflammatory
cytokine levels and markers of glial cell activation in colonic
biopsies from PD patients (Devos et al., 2013). However, the
possible link between DMV–vagus nerve impairment, bowel
inflammation, and development of colonic dysmotility in the
setting of nigrostriatal dopaminergic neurodegeneration re-
quires further confirmation by means of specific experimental
approaches, which could represent a logical continuation of
the ongoing research on this topic.
In conclusion, our results indicate that central nigrostriatal
dopaminergic denervation is associated with an impaired
excitatory neurotransmission characterized by a loss of myen-
teric neuronal ChAT positivity and a decrease in acetylcholine
release, resulting in a dysregulated smoothmuscle motor activity,
which is likely to contribute to the concomitant decrease in
colonic transit. Overall, the present findings provide a trans-
lational basis for better understanding the mechanisms un-
derlying bowel dysfunctions in PD patients.
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